Tivdak (tisotumab vedotin): how was the first human dose set?

Precedia/Antibody-drug conjugates/Tivdak/First dose

Tivdak: how was the first human dose set?

tisotumab vedotin · Tissue factor

First-in-human starting dose

Not stated in public reviews

Why it's blank

The public FDA and EMA reviews of Tivdak don't say how the first human dose was chosen. That rationale is in the IND, which is confidential, so it is missing for most approved products.

How it's usually set for ADCs

ADCs with cytotoxic payloads follow the S9 rules (1/10 STD10 or 1/6 HNSTD of the ADC, scaled by body surface area). For immune agonists, a MABEL-based start dose should be considered instead.

“For example, for cytotoxic payloads, the starting clinical dose can be determined using either 1/10th the Severely Toxic Dose (STD) in 10% of animals (STD10) in rodents or 1/6th the Highest Non- Severely Toxic Dose (HNSTD) in non-rodents, for the ADC based on body surface area, depending on which is the most appropriate and/or sensitive species.”

✓ VerifiedICH 2018: ICH S9 Guideline: Nonclinical Evaluation for Anticancer…, p. 15Source ↗

This product's starting point

NOAEL / key findings: Monkey NOAEL 1 mg/kg (females; <1 mg/kg males), HNSTD 3 mg/kg; skin, bone marrow, eye, testes; skin deaths at 5 mg/kg (EMA assessment report, p. 50)

Full method, every step sourced →

NOAEL / key findings

Monkey NOAEL 1 mg/kg (females; <1 mg/kg males), HNSTD 3 mg/kg; skin, bone marrow, eye, testes; skin deaths at 5 mg/kg

“The NOAEL for males was <1 mg/kg. The applicant also provided exposure (Cmax and AUC) ratios between monkey and human at the highest non-severely toxic dose of 3 mg/kg, which was approximately 1.35- to 2.56-fold that in humans.”

✓ VerifiedEMA assessment report, p. 50Source ↗

Summary across all 14 ADCs →

Tivdak: how was the first human dose set?

Same question, other ADCs

Elahere

Enhertu

Kadcyla

Zynlonta

Adcetris

Besponsa

Datroway

Decnupaz

Emrelis

Mylotarg

Padcev

Polivy

Trodelvy